NCT01607853View on ClinicalTrials.gov

A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Daivobet® gel applied then removed after 10 minutes (+/- 2 minutes)

Once daily application, 3 weeks

DRUG

Daivobet® gel applied then removed after 20 minutes (+/- 2 minutes)

Once daily application, 3 weeks

DRUG

Daivobet® gel applied for 24 hours (+/- 2 hours)

Once daily application, 3 weeks

DRUG

Daivobet® gel vehicle applied for 24 hours (+/- 2 hours)

Once daily application, 3 weeks

Trial Locations (1)

06202

Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD), Nice

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT01607853 - A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris | Biotech Hunter | Biotech Hunter